Form EFFECT Kailera Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 16, 2026 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CICYBELL Introduces New Soft Women's Clothing Collection as Women Embrace Comfort-First Fashion
- Dryden Gold Reports on Deeper Drilling at Spyglass with 9.40 g/t Gold over 4.60 meters at a True Depth of 330 Meters, Provides Marketing Update
- High Tide Reports 91.4 Metres of 28.7% Fe & 112.6 Metres of 27.2% Fe from Labrador West Iron Project
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share